Guardian Pharmacy Services, Inc. cash flow to debt ratio of 270.03% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Guardian Pharmacy Services, Inc.'s free cash flow has increased 94.05% from $41.59M last year to $80.71M, signaling increasing performance

Guardian Pharmacy Services, Inc.'s debt to equity ratio is 0.14, which means that the company's assets are healthy financed, signaling financial stability.

Guardian Pharmacy Services, Inc.'s debt has decreased relative to shareholder equity from 0.26 last year to 0.14 today, signaling strengthened financials

Guardian Pharmacy Services, Inc. has a net cash position, so leverage is healthy.

Guardian Pharmacy Services, Inc.'s interest coverage ratio of 145.39 indicates that earnings with good margin can cover interest payments on company debt

Guardian Pharmacy Services, Inc.'s profit margin has increased (-163.38%) in the last year from -7.11% to 4.50%, signaling increasing performance

Guardian Pharmacy Services, Inc.'s short-term assets of $221.63M exceed its short-term liabilities of $160.70M

Guardian Pharmacy Services, Inc.'s return on assets of 14.86% is higher than the 5.00% threshold, indicating efficient asset utilization

Guardian Pharmacy Services, Inc.'s return on equity of 30.80%, is higher than 15.00%, indicating good performance

Guardian Pharmacy Services, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Guardian Pharmacy Services, Inc. has insufficient public price history to evaluate earnings stability.

Guardian Pharmacy Services, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Guardian Pharmacy Services, Inc. has a free cash flow yield of 3.07%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Guardian Pharmacy Services, Inc.'s yearly earnings has increased -156.39% since last year from $-87.29M to $49.22M, signaling increasing performance

Guardian Pharmacy Services, Inc.'s yearly revenue has increased 17.93% since last year from $1.23B to $1.45B, signaling increasing performance

ROIC 21.45% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Guardian Pharmacy Services, Inc.'s 3-year revenue CAGR of 16.81% is positive, indicating growing revenue over the past 3 years

Guardian Pharmacy Services, Inc. has insufficient public price history to evaluate revenue consistency.

Guardian Pharmacy Services, Inc. has insufficient public price history to evaluate ROE consistency.

Guardian Pharmacy Services, Inc. is overvalued relative to its fair value price of 22.95 based on Discounted Cash Flow model

Guardian Pharmacy Services, Inc. has an earnings yield of 2.51%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Guardian Pharmacy Services, Inc. is overvalued relative to its fair value price of 12.63 based on EBITDA multiple model

Guardian Pharmacy Services, Inc. has an EV/EBITDA ratio of 26.94x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Guardian Pharmacy Services, Inc. has insufficient data to evaluate this check.

Guardian Pharmacy Services, Inc. has a PEG-ratio over 1 which is considered overvalued

Guardian Pharmacy Services, Inc. has a price-to-book ratio of 10.19x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Guardian Pharmacy Services, Inc. has a price-to-sales ratio of 1.79x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue